COST-UTILITY ANALYSIS OF DUPILUMAB IN ADULTS AND ADOLESCENTS WITH UNCONTROLLED PERSISTENT SEVERE ASTHMA IN PORTUGAL

C. Silva, P. Carreiro-Martins, J. Ferreira, A. Arrobas, A. Mendes, M. Faria, F. N. Rocha-Goncalves

Research output: Contribution to journal › Meeting Abstract › peer-review

Cite this

@article{f9d12aa12b8f475b9a8e255aa06be5a7,

title = "COST-UTILITY ANALYSIS OF DUPILUMAB IN ADULTS AND ADOLESCENTS WITH UNCONTROLLED PERSISTENT SEVERE ASTHMA IN PORTUGAL",

author = "C. Silva and P. Carreiro-Martins and J. Ferreira and A. Arrobas and A. Mendes and M. Faria and Rocha-Goncalves, {F. N.}",

year = "2022",

month = dec,

language = "English",

volume = "25",

pages = "S166--S167",

journal = "Value In Health",

issn = "1098-3015",

publisher = "Elsevier",

number = "12",

}

TY - JOUR

T1 - COST-UTILITY ANALYSIS OF DUPILUMAB IN ADULTS AND ADOLESCENTS WITH UNCONTROLLED PERSISTENT SEVERE ASTHMA IN PORTUGAL

AU - Silva, C.

AU - Carreiro-Martins, P.

AU - Ferreira, J.

AU - Arrobas, A.

AU - Mendes, A.

AU - Faria, M.

AU - Rocha-Goncalves, F. N.

PY - 2022/12

Y1 - 2022/12

M3 - Meeting Abstract

SN - 1098-3015

VL - 25

SP - S166-S167

JO - Value In Health

JF - Value In Health

IS - 12

ER -